Among the nine variant-positive cases in the KRAS experiment, eight were EGFR mutation-negative lung cancers that had substitutions in codon 12, and one was an EGFR mutation-positive case in which the substitutions were non-synonymous and located outside of the hotspot region. This evidence concerns the gene KRAS and lung cancer.